| Literature DB >> 27839693 |
Ontida Apinorasethkul1, Maura Kirk2, Kevin Teo2, Samuel Swisher-McClure2, John N Lukens2, Alexander Lin2.
Abstract
Patients diagnosed with head and neck cancer are traditionally treated with photon radiotherapy. Proton therapy is currently being used clinically and may potentially reduce treatment-related toxicities by minimizing the dose to normal organs in the treatment of postoperative oropharyngeal cancer. The finite range of protons has the potential to significantly reduce normal tissue toxicity compared to photon radiotherapy. Seven patients were planned with both proton and photon modalities. The planning goal for both modalities was achieving the prescribed dose to 95% of the planning target volume (PTV). Dose-volume histograms were compared in which all cases met the target coverage goals. Mean doses were significantly lower in the proton plans for the oral cavity (1771cGy photon vs 293cGy proton, p < 0.001), contralateral parotid (1796cGy photon vs 1358 proton, p < 0.001), and the contralateral submandibular gland (3608cGy photon vs 3251cGy proton, p = 0.03). Average total integral dose was 9.1% lower in proton plans. The significant dosimetric sparing seen with proton therapy may lead to reduced side effects such as pain, weight loss, taste changes, and dry mouth. Prospective comparisons of protons vs photons for disease control, toxicity, and patient-reported outcomes are therefore warranted and currently being pursued.Entities:
Keywords: Head and neck; Oropharyngeal cancer; Proton therapy; Rapid arc
Mesh:
Year: 2016 PMID: 27839693 DOI: 10.1016/j.meddos.2016.09.004
Source DB: PubMed Journal: Med Dosim ISSN: 1873-4022 Impact factor: 1.482